BGLC: Bionexus Gene Lab Corp Financial Statements
Balance sheet, income statement, and cash flow statements for Bionexus Gene Lab Corp (BGLC).
$5.03M Market Cap.
BGLC Market Cap. (MRY)
BGLC Shares Outstanding (MRY)
BGLC Assets (MRY)
Total Assets
$10.43M
Total Liabilities
$2.11M
Total Investments
$4.06M
BGLC Income (MRY)
Revenue
$9.51M
Net Income
-$1.60M
Operating Expense
$4.94M
BGLC Cash Flow (MRY)
CF Operations
-$2.23M
CF Investing
$418.20K
CF Financing
$144.97K
BGLC Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $10,433,848 (-8.47%) | $11,399,793 (30.43%) | $8,740,162 (-8.71%) | $9,574,390 (-5.35%) |
Assets Current | $7,430,449 (-7.66%) | $8,046,800 (33.63%) | $6,021,826 (-15.78%) | $7,149,855 (-10.46%) |
Assets Non-Current | $3,003,399 (-10.43%) | $3,352,993 (23.35%) | $2,718,336 (12.12%) | $2,424,535 (13.84%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $8,322,804 (-13.82%) | $9,657,852 (44.90%) | $6,665,013 (-7.17%) | $7,179,779 (7.77%) |
Property Plant & Equipment Net | $1,738,233 (5.15%) | $1,653,162 (5.47%) | $1,567,438 (-6.45%) | $1,675,508 (-9.34%) |
Cash & Equivalents | $1,583,479 (-39.65%) | $2,623,965 (328.86%) | $611,849 (5.76%) | $578,511 (-17.31%) |
Accumulated Other Comprehensive Income | -$555,000 (18.06%) | -$677,294 (-65.57%) | -$409,062 (-307.99%) | -$100,262 (-175.00%) |
Deferred Revenue | $95,879 (0%) | $0 (0%) | $23,123 (-78.51%) | $107,583 (0%) |
Total Investments | $4,059,114 (-18.90%) | $5,005,202 (232.13%) | $1,507,015 (-34.32%) | $2,294,435 (-3.18%) |
Investments Current | $2,793,948 (-15.47%) | $3,305,371 (0%) | $0 (0%) | $1,545,408 (-25.99%) |
Investments Non-Current | $1,265,166 (-25.57%) | $1,699,831 (47.70%) | $1,150,898 (53.65%) | $749,027 (165.93%) |
Inventory | $1,388,624 (22.05%) | $1,137,770 (16.36%) | $977,807 (-35.75%) | $1,521,915 (29.40%) |
Trade & Non-Trade Receivables | $1,580,231 (71.37%) | $922,106 (-68.13%) | $2,893,604 (-15.80%) | $3,436,415 (-14.51%) |
Trade & Non-Trade Payables | $1,503,326 (7.21%) | $1,402,180 (-24.66%) | $1,861,015 (-7.52%) | $2,012,266 (-36.53%) |
Accumulated Retained Earnings (Deficit) | -$3,442,620 (-86.66%) | -$1,844,278 (-259.49%) | $1,156,392 (-23.54%) | $1,512,358 (98.79%) |
Tax Assets | $84,167 (46.15%) | $57,588 (82.52%) | $31,551 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $12,255 (-60.30%) | $30,866 (-75.50%) | $126,001 (99.42%) |
Total Debt | $227,731 (55.35%) | $146,594 (158.20%) | $56,775 (-26.22%) | $76,947 (-37.65%) |
Debt Current | $67,990 (42.15%) | $47,831 (188.68%) | $16,569 (-58.06%) | $39,507 (-13.65%) |
Debt Non-Current | $159,741 (61.74%) | $98,763 (145.64%) | $40,206 (7.39%) | $37,440 (-51.80%) |
Total Liabilities | $2,111,044 (21.19%) | $1,741,941 (-16.06%) | $2,075,149 (-13.34%) | $2,394,611 (-30.65%) |
Liabilities Current | $1,951,303 (19.64%) | $1,630,923 (-18.62%) | $2,004,077 (-13.94%) | $2,328,755 (-30.97%) |
Liabilities Non-Current | $159,741 (43.89%) | $111,018 (56.20%) | $71,072 (7.92%) | $65,856 (-17.20%) |
BGLC Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $9,510,646 (-2.66%) | $9,770,806 (-10.60%) | $10,928,707 (-18.21%) | $13,362,567 (17.31%) |
Cost of Revenue | $8,221,125 (-2.61%) | $8,441,308 (-12.70%) | $9,669,678 (-12.85%) | $11,095,626 (14.74%) |
Selling General & Administrative Expense | $4,004,652 (31.74%) | $3,039,713 (75.76%) | $1,729,489 (35.37%) | $1,277,605 (-4.15%) |
Research & Development Expense | $47,511 (-13.59%) | $54,982 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $4,935,696 (11.94%) | $4,409,122 (154.94%) | $1,729,489 (35.37%) | $1,277,605 (-4.15%) |
Interest Expense | $21,146 (51.81%) | $13,929 (11.62%) | $12,479 (-3.81%) | $12,973 (14.67%) |
Income Tax Expense | $3,494 (-83.77%) | $21,526 (-58.85%) | $52,310 (-82.04%) | $291,283 (72.96%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$1,598,342 (39.20%) | -$2,629,043 (-638.57%) | -$355,966 (-147.36%) | $751,571 (-31.31%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$1,598,342 (39.20%) | -$2,629,043 (-638.57%) | -$355,966 (-147.36%) | $751,571 (-31.31%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$1,598,342 (39.20%) | -$2,629,043 (-638.57%) | -$355,966 (-147.36%) | $751,571 (-31.31%) |
Weighted Average Shares | $1,781,848 (12.24%) | $1,587,546 (10.17%) | $1,440,973 (0.99%) | $1,426,817 (66.36%) |
Weighted Average Shares Diluted | $1,781,848 (12.24%) | $1,587,546 (10.17%) | $1,440,973 (0.99%) | $1,426,817 (66.36%) |
Earning Before Interest & Taxes (EBIT) | -$1,573,702 (39.32%) | -$2,593,588 (-790.73%) | -$291,177 (-127.58%) | $1,055,827 (-17.11%) |
Gross Profit | $1,289,521 (-3.01%) | $1,329,498 (5.60%) | $1,259,029 (-44.46%) | $2,266,941 (31.81%) |
Operating Income | -$3,646,175 (-18.40%) | -$3,079,624 (-554.60%) | -$470,460 (-147.55%) | $989,336 (155.72%) |
BGLC Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $418,202 (123.31%) | -$1,794,202 (-298.27%) | -$450,498 (8.17%) | -$490,574 (-137.16%) |
Net Cash Flow from Financing | $144,975 (-97.69%) | $6,274,939 (5701.10%) | $108,168 (483.28%) | -$28,222 (-470.49%) |
Net Cash Flow from Operations | -$2,234,260 (-22.61%) | -$1,822,212 (-430.22%) | $551,822 (5923.60%) | $9,161 (-98.34%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$1,630,744 (-167.98%) | $2,398,846 (47554.92%) | -$5,055 (99.24%) | -$663,773 (-134.42%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $497,210 (129.14%) | -$1,706,213 (-233.44%) | -$511,706 (-0.44%) | -$509,448 (-548.38%) |
Capital Expenditure | -$226,989 (-51.94%) | -$149,398 (-175.79%) | -$54,171 (-1613.19%) | -$3,162 (-100.30%) |
Issuance (Repayment) of Debt Securities | $3,975 (-69.88%) | $13,199 (138.78%) | -$34,038 (-20.61%) | -$28,222 (-470.49%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $5,750,000 (3733.33%) | $150,000 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $40,339 (115.53%) | -$259,679 (-21.04%) | -$214,547 (-39.19%) | -$154,138 (-353.13%) |
Share Based Compensation | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Depreciation Amortization & Accretion | $153,143 (41.25%) | $108,423 (2.85%) | $105,419 (-2.58%) | $108,215 (6.51%) |
BGLC Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 13.60% (0.00%) | 13.60% (18.26%) | 11.50% (-32.35%) | 17.00% (12.58%) |
Profit Margin | -16.80% (37.55%) | -26.90% (-715.15%) | -3.30% (-158.93%) | 5.60% (-41.67%) |
EBITDA Margin | -14.90% (41.34%) | -25.40% (-1394.12%) | -1.70% (-119.54%) | 8.70% (-28.10%) |
Return on Average Equity (ROAE) | -17.50% (46.97%) | -33.00% (-522.64%) | -5.30% (-149.07%) | 10.80% (-76.32%) |
Return on Average Assets (ROAA) | -14.60% (45.93%) | -27.00% (-542.86%) | -4.20% (-153.85%) | 7.80% (-76.29%) |
Return on Sales (ROS) | -16.50% (37.74%) | -26.50% (-881.48%) | -2.70% (-134.18%) | 7.90% (-29.46%) |
Return on Invested Capital (ROIC) | -21.00% (50.24%) | -42.20% (-817.39%) | -4.60% (-128.22%) | 16.30% (-72.42%) |
Dividend Yield | 0% (0%) | 0% | - | - |
Price to Earnings Ratio (P/E) | -3.11 (2.66%) | -3.19 | - | - |
Price to Sales Ratio (P/S) | 0.52 (-39.14%) | 0.86 | - | - |
Price to Book Ratio (P/B) | 0.6 (-37.73%) | 0.97 | - | - |
Debt to Equity Ratio (D/E) | 0.25 (41.11%) | 0.18 (-42.12%) | 0.31 (-6.89%) | 0.33 (-35.52%) |
Earnings Per Share (EPS) | -0.9 (45.78%) | -1.66 (-260.87%) | -0.46 (-195.83%) | 0.48 (-66.67%) |
Sales Per Share (SPS) | 5.34 (-13.27%) | 6.16 (-18.84%) | 7.58 (-19.02%) | 9.37 (-29.49%) |
Free Cash Flow Per Share (FCFPS) | -1.38 (-11.19%) | -1.24 (-460.00%) | 0.34 (8525.00%) | 0 (-99.79%) |
Book Value Per Share (BVPS) | 4.67 (-23.22%) | 6.08 (31.55%) | 4.63 (-8.09%) | 5.03 (-35.22%) |
Tangible Assets Book Value Per Share (TABVPS) | 5.86 (-18.45%) | 7.18 (18.40%) | 6.07 (-9.61%) | 6.71 (-43.11%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (0.00%) | -2 | - | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.26 (-16.99%) | -1.93 | - | - |
Asset Turnover | 0.87 (-13.26%) | 1 (-21.82%) | 1.28 (-7.16%) | 1.38 (-59.61%) |
Current Ratio | 3.81 (-22.82%) | 4.93 (64.19%) | 3 (-2.12%) | 3.07 (29.70%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$2,461,249 (-24.83%) | -$1,971,610 (-496.18%) | $497,651 (8195.57%) | $5,999 (-99.62%) |
Enterprise Value (EV) | $3,208,981 (-33.12%) | $4,797,858 | - | - |
Earnings Before Tax (EBT) | -$1,594,848 (38.84%) | -$2,607,517 (-758.71%) | -$303,656 (-129.12%) | $1,042,854 (-17.40%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$1,420,559 (42.84%) | -$2,485,165 (-1237.85%) | -$185,758 (-115.96%) | $1,164,042 (-15.37%) |
Invested Capital | $7,126,797 (-2.26%) | $7,291,499 (17.97%) | $6,181,011 (-8.35%) | $6,744,071 (9.38%) |
Working Capital | $5,479,146 (-14.60%) | $6,415,877 (59.69%) | $4,017,749 (-16.66%) | $4,821,100 (4.54%) |
Tangible Asset Value | $10,433,848 (-8.47%) | $11,399,793 (30.43%) | $8,740,162 (-8.71%) | $9,574,390 (-5.35%) |
Market Capitalization | $5,025,555 (-46.33%) | $9,363,879 | - | - |
Average Equity | $9,150,230 (14.86%) | $7,966,560 (17.86%) | $6,759,596 (-2.87%) | $6,959,260 (190.09%) |
Average Assets | $10,932,528 (12.27%) | $9,737,724 (14.28%) | $8,520,633 (-11.90%) | $9,671,512 (190.53%) |
Invested Capital Average | $7,499,900 (22.01%) | $6,146,742 (-2.65%) | $6,313,798 (-2.57%) | $6,480,658 (200.70%) |
Shares | 1,796,766 (1.70%) | 1,766,766 (22.04%) | 1,447,651 (1.46%) | 1,426,817 (66.67%) |
